Agnes Y Y Lee Selected Research

Agnes Y Y Lee Research Topics

Disease

62	Neoplasms (Cancer) 05/2024 - 06/2003
41	Hemorrhage 05/2024 - 05/2002
39	Venous Thromboembolism 05/2024 - 05/2002
27	Thrombosis (Thrombus) 04/2023 - 05/2002
11	Venous Thrombosis (Deep-Vein Thrombosis) 11/2023 - 05/2003
8	COVID-19 07/2022 - 08/2020
7	Pulmonary Embolism 12/2019 - 07/2003
5	Thrombocytopenia (Thrombopenia) 05/2022 - 07/2015
4	Inflammation (Inflammations) 07/2022 - 01/2004
3	Critical Illness (Critically Ill) 07/2022 - 10/2020
3	Atrial Fibrillation 09/2021 - 11/2019
2	Leukemia 07/2023 - 10/2018
2	Embolism (Embolus) 01/2020 - 11/2019
2	Thromboembolism 11/2019 - 07/2003
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 11/2023
1	Lymphoma (Lymphomas) 10/2022
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 05/2022
1	Brain Neoplasms (Brain Tumor) 10/2020
1	Urogenital Neoplasms 10/2020
1	Cytokine Release Syndrome 01/2020
1	Transient Ischemic Attack 11/2019
1	Ischemic Stroke 11/2019
1	Chronic Disease (Chronic Diseases) 01/2018
1	Fatigue 01/2018
1	Polyarteritis Nodosa (Periarteritis Nodosa) 08/2014
1	Urticaria (Hives) 08/2014
1	Neoplasm Metastasis (Metastasis) 05/2014
1	Pain (Aches) 01/2012
1	Postphlebitic Syndrome 03/2006
1	Hypoxia (Hypoxemia) 01/2004
1	Thrombophilia 01/2004
1	Body Weight (Weight, Body) 07/2003

Drug/Important Bio-Agent (IBA)

43	AnticoagulantsIBA 02/2024 - 05/2002
29	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 05/2024 - 06/2003
13	RivaroxabanIBA 05/2024 - 01/2018
9	Warfarin (Coumadin)FDA LinkGeneric 10/2022 - 09/2003
9	Heparin (Liquaemin)FDA LinkGeneric 05/2022 - 12/2003
9	fibrin fragment D (D-dimer)IBA 05/2022 - 05/2003
9	Vitamin K FDA Link 09/2019 - 02/2005
7	apixabanIBA 07/2023 - 01/2019
5	Tinzaparin (Innohep)FDA Link 01/2018 - 06/2013
4	Antineoplastic Agents (Antineoplastics)IBA 01/2010 - 06/2003
3	edoxabanIBA 10/2022 - 05/2020
3	Thromboplastin (Tissue Factor)IBA 01/2022 - 01/2004
3	Biomarkers (Surrogate Marker)IBA 01/2020 - 06/2013
3	Dalteparin (Dalteparin Sodium)FDA Link 05/2019 - 07/2003
3	coumarinIBA 05/2019 - 07/2003
2	VaccinesIBA 05/2022 - 01/2022
2	AntibodiesIBA 05/2022 - 10/2020
2	Dabigatran FDA Link 11/2019 - 07/2015
2	CreatinineIBA 11/2019 - 07/2015
2	CoumarinsIBA 04/2005 - 07/2003
1	Factor Xa InhibitorsIBA 04/2023
1	Interleukin-6 InhibitorsIBA 07/2022
1	tocilizumab (atlizumab)FDA Link 07/2022
1	Dexamethasone (Maxidex)FDA LinkGeneric 07/2022
1	COVID-19 VaccinesIBA 05/2022
1	ChAdOx1 nCoV-19IBA 05/2022
1	Serotonin (5 Hydroxytryptamine)IBA 05/2022
1	Ad26COVS1IBA 05/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	CytokinesIBA 01/2021
1	Fondaparinux (Arixtra)FDA Link 01/2021
1	Blood Group Antigens (Blood Groups)IBA 10/2020
1	ABO Blood-Group SystemIBA 10/2020
1	Factor Xa (Coagulation Factor Xa)IBA 05/2020
1	Chimeric Antigen ReceptorsIBA 01/2020
1	vinyltriethoxysilane (VTES)IBA 05/2016
1	Gastrointestinal AgentsIBA 12/2014
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 04/2012
1	E-SelectinIBA 01/2004
1	P-SelectinIBA 01/2004
1	P-selectin ligand proteinIBA 01/2004
1	LatexIBA 05/2003

Therapy/Procedure

33	Therapeutics 10/2022 - 05/2002
6	Drug Therapy (Chemotherapy) 01/2021 - 03/2006
4	Central Venous Catheters 10/2018 - 03/2006
3	Catheters 10/2018 - 03/2006
2	Artificial Respiration (Mechanical Ventilation) 10/2021 - 10/2020
2	Secondary Prevention 01/2018 - 12/2003
2	Contraindications 08/2015 - 04/2014
1	Anesthesia 09/2023
1	Immunomodulation 05/2022
1	Operative Surgical Procedures 01/2021
1	Cardiopulmonary Resuscitation (CPR) 12/2019
1	Platelet Transfusion (Blood Platelet Transfusions) 10/2018
1	Vena Cava Filters (Inferior Vena Cava Filter) 10/2009
1	Duration of Therapy 10/2009
1	Subcutaneous Injections 12/2003